Anti-CAR-engineered T cells for epitope-based elimination of autologous CAR T cells

Although CAR T-cell therapy has demonstrated tremendous clinical efficacy especially in hematological malignancies, severe treatment-associated toxicities still compromise the widespread application of this innovative technology. Therefore, developing novel approaches to abrogate CAR T-cell-mediated...

Descripción completa

Detalles Bibliográficos
Autores principales: Koristka, Stefanie, Ziller-Walter, Pauline, Bergmann, Ralf, Arndt, Claudia, Feldmann, Anja, Kegler, Alexandra, Cartellieri, Marc, Ehninger, Armin, Ehninger, Gerhard, Bornhäuser, Martin, Bachmann, Michael P.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2019
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6768917/
https://www.ncbi.nlm.nih.gov/pubmed/31414180
http://dx.doi.org/10.1007/s00262-019-02376-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6768917/
https://www.ncbi.nlm.nih.gov/pubmed/31414180
http://dx.doi.org/10.1007/s00262-019-02376-y

Ejemplares similares